As of 2025-05-19, the Fair Value of Ovid Therapeutics Inc (OVID) is -9.30 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.30 USD, the upside of Ovid Therapeutics Inc is -3,168.18%.
With the market price of 0.30 USD and our fair value calculation, Ovid Therapeutics Inc (OVID) is not a good investment. Investing in OVID stocks now will result in a potential loss of 3,168.18%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -81.00 | 122.80 | -54.20 | -52.34 | -26.43 | -18.23 |
| YoY growth | -33.88% | 251.60% | -144.14% | 3.43% | 49.50% | 25.30% |
| Market Cap (mil) | 21.54 |
| P/E | |
| Forward P/E |
| EPS | -0.37 |
| Avg earnings growth rate | 25.30% |
| TTM earnings | -26.43 |